Drug for severe pneumonia and preparation method thereof

Abstract

The invention discloses a drug for severe pneumonia and a preparation method thereof. Medicinal active ingredients of the drug include raw gypsum, rhizoma anemarrhenae, polished round-grained rice, raw licorice, bulbs of thunberg fritillary, snake gourd seeds, rhizoma pinellinae praeparata, radix platycodi, fried Chinese ephedra herbs, almonds, ginseng, the root of dwarf lilyturf, fruits of Chinese magnoliavine, the root bark of the peony tree and the root of common peony. The drug has the effects of clearing away heat and phlegm, promoting catharsis, supplementing qi, strengthening the body resistance, activating blood circulation, removing blood stasis, and protecting the spleen and the stomach; the drug for treating the severe pneumonia has high practicability, and the anti-infection ability of antibiotics is enhanced through the compound effect of clearing the lungs and removing the phlegm; through the effect of supplementing the qi and strengthening the body resistance, the immunity and disease resistance are improved, and infections of fungi, viruses and non-specific pathogens are reduced; through the compound effect of ventilating lung qi, respiratory functions are improved,and coughing, expectoration and the like are reduced; through the effect of cooling the blood and promoting the blood circulation, the incidence of coagulation disorders is reduced; through the effect of tonifying the stomach and protecting the spleen, appetite and disease recovery are promoted, and the occurrence of stress ulcers and bacteria group displacement is reduced.

Description

technical field

[0001] The invention relates to a medicine for severe pneumonia and a preparation method thereof, belonging to the field of pharmaceutical technology. Background technique

[0002] The definition of pneumonia is that the inflammation of lung tissue (bronchioles, alveoli, interstitium) develops to a certain stage and deteriorates and aggravates, causing organ dysfunction and even life-threatening, with a case fatality rate as high as 30%-50%.

[0003] diagnosis

[0004] 1.1.1 Reference standard for clinical diagnosis of pneumonia

[0005] Guidelines for the diagnosis and treatment of hospital-acquired pneumonia and ventilator-associated pneumonia in Chinese adults 2018 edition: main criteria + 2 minor criteria;

[0006] Main criteria: Chest X-ray or CT shows new or progressive infiltration, consolidation or ground-glass opacity;

[0007] Minor criteria: ① fever, body temperature > 38°C; ② purulent airway secretions; ③ peripheral blood white blood cell co...

Images